Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events
- 27 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (16), 2079-2084
- https://doi.org/10.1161/01.cir.99.16.2079
Abstract
Background—A growing body of evidence suggests a role for inflammation in acute coronary syndromes. The aim of this study was to assess the role of proinflammatory cytokines, their time course, and...Keywords
This publication has 37 references indexed in Scilit:
- Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shockCritical Care Medicine, 1996
- Episodic activation off the coagulation system in unstable angina does not elicit an acute phase reactionThe American Journal of Cardiology, 1996
- Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient miceImmunity, 1995
- Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injuryCritical Care Medicine, 1995
- Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptorsEuropean Journal of Clinical Investigation, 1994
- Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trialCritical Care Medicine, 1994
- Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cellsAtherosclerosis, 1993
- Production of interleukin-1-receptor antagonist during experimental endotoxaemiaThe Lancet, 1991
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.JCI Insight, 1989